MAP2K1 and cystic fibrosis: Together, these results demonstrate that MEK1/2 inhibitors significantly reduce CF macrophage production of a subset of both TLR4- and TLR2-dependent pro-inflammatory cytokines associated with neutrophil recruitment and tissue damage.